Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

NRXPNRXP
Showing 8 of 9 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in NRX PHARMACEUTICALS INC

GEODE CAPITAL MANAGEMENT, LLC holds 314,659 shares of NRXP (NRX PHARMACEUTICALS INC), worth $1.3M as of 2026-Q2. The position was increased (+1.5% shares). NRXP represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$1.3M

Current Shares

314,659

Total Value Change

+$1.2M

Total Shares Change

+237,318

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
314,659
+1.5%
$1.3M0.0%$4.09
26
2026-Q1
Increased
310,112
+41.7%
$660,6090.0%$1.80
22
2025-Q4
Increased
218,866
+17.8%
$593,2120.0%$2.63
19
2025-Q3
Increased
185,862
+7.9%
$613,4550.0%$3.25
18
2025-Q2
Increased
172,255
+27.9%
$561,5960.0%$3.42
21
2025-Q1
Increased
134,657
+81.3%
$276,0810.0%$2.03
24
2024-Q4
Decreased
74,251
-4.0%
$163,3890.0%$1.53
0
2024-Q3
Increased
77,341
+17.8%
$130,7280.0%$1.75
18

Other major holders of NRXP: VANGUARD CAPITAL MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, BALYASNY ASSET MANAGEMENT L.P., CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used